Skip to content

Author

Indrani Datta

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Generation of a CRISPR/Cas9-corrected isogenic control iPSC line (NIMHi001-A-1) from a Parkinson's disease Patient-Derived iPSC line carrying the LRRK2 I1371V mutation.

The NIMHi001-A-1 line demonstrated trilineage differentiation potential and tested negative for mycoplasma, providing an isogenic platform to investigate LRRK2 I1371V-specific pathomechanisms and evaluate therapeutic strategies.

Roon Banerjee, Khushboo Singh, Ujaswini Gogoi et al. · 0 citations
Review 2026

Glial control of extracellular α-synuclein propagation in LRRK2 Parkinson's disease.

This review synthesises current evidence on how mutations in Leucine-Rich Repeat Kinase 2 (LRRK2), the most common genetic cause of familial PD, fundamentally corrupt glial handling of extracellular α-synuclein and evaluates emerging therapeutic strategies targeting LRRK2 kinase activity, NLRP3 inflammasome activation,...

Indrani Datta, Dibyam Debasish Sahu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.